JASUPA Trademark

Trademark Overview


On Monday, February 1, 2016, a trademark application was filed for JASUPA with the United States Patent and Trademark Office. The USPTO has given the JASUPA trademark a serial number of 86892623. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 10, 2023. This trademark is owned by Glaxo Group Limited. The JASUPA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
jasupa

General Information


Serial Number86892623
Word MarkJASUPA
Filing DateMonday, February 1, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 10, 2023
Registration Number5031923
Registration DateTuesday, August 30, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVIIV HEALTHCARE UK (NO. 3) LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBRENTFORD, MIDDLESEX TW8 9GS

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Friday, March 10, 2023CANCELLED SEC. 8 (6-YR)
Thursday, September 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 30, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 20, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 30, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, June 14, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 25, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 5, 2016ASSIGNED TO EXAMINER
Thursday, February 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 4, 2016NEW APPLICATION ENTERED